$0.5505
-0.05-8.00%
Pre-Market: 6:35 PM EDT
Comments
Loading...
Entero Therapeutics (ENTO) Forecast
NewsEarningsEntero Therapeutics (ENTO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Entero Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ENTO | Benzinga
Explore Entero Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ENTO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Entero Therapeutics (ENTO) stock?
You can purchase shares of Entero Therapeutics (NASDAQ:ENTO) through any online brokerage.
Who are Entero Therapeutics (ENTO) competitors?
Other companies in Entero Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and NuCana (NASDAQ:NCNA).
What is the forecast, or price target, for Entero Therapeutics (ENTO) stock?
There is no analysis for Entero Therapeutics to provide a consensus price target.
What is the current price for Entero Therapeutics (ENTO)?
The stock price for Entero Therapeutics (NASDAQ: ENTO) is $0.5505 last updated March 24, 2025 at 6:35 PM EDT.
Does Entero Therapeutics (ENTO) pay a dividend?
There are no upcoming dividends for Entero Therapeutics.
When is Entero Therapeutics (NASDAQ:ENTO) reporting earnings?
Entero Therapeutics’s Q4 earnings are confirmed for Tuesday, May 20, 2025.
Is Entero Therapeutics (ENTO) going to split?
There is no upcoming split for Entero Therapeutics.
What sector and industry does Entero Therapeutics (ENTO) operate in?
Entero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.